September 24, 2024
7,651
97
33
1.70%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
2:14:30Now PlayingSen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor and Pensions (HELP) Committee, is set to grill Novo Nordisk CEO Lars Jorgenson Tuesday morning over prices on the drugmaker’s popular weight loss drugs, including Ozempic and Wegovy.
The drugs, which both contain the active ingredient semaglutide, are also used to treat type 2 diabetes.
Sanders launched an investigation into the company’s prices earlier this year, laying out concerns over various price discrepancies between the drugs and between different countries.
The hearing is scheduled to begin at 10 a.m. EDT.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.